You are here: Industry Insights > antibody drug

News List

Sparx Therapeutics to build first commercial antibody drug production facility in China cphi-online
July 15, 2021
The emerging biotech company unveils plans for a 1.2 million-sq. ft manufacturing facility in Yangzhou
Sanyou Biopharmaceuticals completes series B financing and secures its leading role in innovative antibody drug discovery firstwordpharma
June 28, 2021
Sanyou Biopharmaceutical (Shanghai) Co., Ltd. (hereafter referred to as "Sanyou Bio" or "the Company"), a leading company in innovative antibody drug discovery, announced the closing of series B financing.
Hummingbird and Cancer Research UK to develop antibody drug HMBD-001 pharmaceutical-technology
August 09, 2019
Biotechnology company Hummingbird Bioscience and Cancer Research UK have collaborated to develop the former’s anti-HER3 clinical grade antibody drug, HMBD-001 to treat people with HER3 driven cancer.
ProMIS Neurosciences Identifies Novel Antibody Drug Candidates for Parkinson's Disease americanpharmaceuticalreview
October 12, 2018
ProMIS Neurosciences announced the identification of several potential antibody therapeutic candidates aimed at selectively targeting toxic oligomers of the protein α-synuclein, considered a root cause of Parkinson's disease (PD).
Daiichi Sankyo Announces Manufacturing Investment to Support Antibody Drug Conjugate Portfolio americanpharmaceuticalreview
April 28, 2017
Daiichi Sankyo Company announced it is making an initial 15 billion yen investment to optimize and enhance its manufacturing capabilities to support its antibody drug conjugate (ADC) pipeline.
Novimmune and LegoChem evaluate antibody drug conjugate candidate pharmaceutical-technology
February 15, 2017
Swiss biotech company Novimmune and South Korean-based LegoChem Biosciences (LCB) have entered a research collaboration to evaluate an antibody drug conjugate candidate.